18 Publications
2018
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity
Özeş, Ali R⋅Özeş, Ali⋅Pulliam, Nick⋅Pulliam, Nick⋅Ertosun, Mustafa G⋅Ertosun, Mustafa⋅Yılmaz, Özlem⋅Yılmaz, Özlem⋅Tang, Jessica⋅Tang, Jessica⋅Çopuroğlu, Ece⋅Çopuroğlu, Ece⋅Matei, Daniela⋅Matei, Daniela⋅Özeş, Osman⋅Özeş, Osman N⋅Nephew, Kenneth P and Nephew, Kenneth
Oncogene, vol. 37, (no. 26), pp. 3589-3600, Jun 2018. | Journal Article
2013
Live tissue viability and chemosensitivity assays using digital holographic motility contrast imaging.
An, Ran⋅Turek, John J⋅Matei, Daniela E and Nolte, David D
Applied optics, vol. 52, (no. 1), pp. A300-9, 2013/Jan/1. | Journal Article
2010
Continued chemotherapy after complete response to primary therapy among women with advanced ovarian cancer: a meta-analysis.
Hess, Lisa⋅Rong, Nan⋅Monahan, Patrick O⋅Gupta, Paridha⋅Thomaskutty, Champ and Matei, Daniela
Cancer, vol. 116, (no. 22), pp. 5251-60, 2010/Nov/15. | Journal Article
 
Role of epigenomics in ovarian and endometrial cancers.
Balch, Curtis⋅Matei, Daniela E⋅Huang, Tim H and Nephew, Ken
Epigenomics, vol. 2, (no. 3), pp. 419-47, 2010/Jun. | Journal Article
2009
Breast mass in a patient with ovarian cancer: a case report.
Gayathri, Suresh⋅Gayathri, Suresh⋅Badve, Sunil⋅Badve, Sunil⋅Matei, Daniela and Matei, Daniela E
The Journal of reproductive medicine, vol. 54, (no. 10), pp. 639-44, 2009/Oct. | Journal Article
 
Tissue Transglutaminase Regulates Matrix Metalloproteinase-2 in Ovarian Cancer by Modulating cAMP- response Element-binding Protein Activity
Satpathy, Minati⋅Shao, Minghai⋅Emerson, Robert⋅Donner, David B and Matei, Daniela E
Journal of Biological Chemistry, vol. 284, (no. 23), pp. 15390-15399, 2009. | Journal Article
2008
Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis : a Hoosier Oncology Group trial.
Matei, Daniela⋅Matei, Daniela⋅Matei, Daniela E⋅Emerson, Robert E⋅Emerson, Robert E⋅Emerson, Robert E⋅Schilder, Jeanne⋅Schilder, Jeanne⋅Schilder, Jeanne⋅Menning, Nancy⋅Menning, Nancy⋅Menning, Nancy⋅Baldridge, Lee Ann⋅Baldridge, Lee A⋅Baldridge, Lee Ann⋅Johnson, Cynthia S⋅Johnson, Cynthia S⋅Johnson, Cynthia S⋅Breen, Tim⋅Breen, Tim⋅Breen, Tim⋅McClean, John⋅McClean, John⋅McClean, John⋅Stephens, Doyle⋅Stephens, Doyle⋅Stephens, Doyle⋅Whalen, Charles⋅Whalen, Charles⋅Whalen, Charles⋅Sutton, Gregory⋅Sutton, Gregory and Sutton, Gregory
Cancer, vol. 113, (no. 4), pp. 723-32, 2008/Aug/15. | Journal Article
2007
Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase.
Satpathy, Minati⋅Satpathy, Minati⋅Cao, Liyun⋅Cao, Liyun⋅Pincheira, Roxana⋅Pincheira, Roxana⋅Emerson, Robert⋅Emerson, Robert⋅Bigsby, Robert M⋅Bigsby, Robert⋅Nakshatri, Harikrishna⋅Nakshatri, Harikrishna⋅Matei, Daniela and Matei, Daniela E
Cancer research, vol. 67, (no. 15), pp. 7194-202, 2007/Aug/1. | Journal Article
 
Novel agents in ovarian cancer.
Matei, Daniela E
Expert opinion on investigational drugs, vol. 16, (no. 8), pp. 1227-39, 2007/Aug. | Journal Article
 
The Platelet-derived Growth Factor Receptor alpha Is Destabilized by Geldanamycins in Cancer Cells
Matei, Daniela E⋅Satpathy, Minati⋅Cao, Liyun⋅Lai, Yi-Chun⋅Nakshatri, Harikrishna and Donner, David B
Journal of Biological Chemistry, vol. 282, (no. 1), pp. 445-453, 2007. | Journal Article
 
The Platelet-derived Growth Factor Receptor α Is Destabilized by Geldanamycins in Cancer Cells
Matei, Daniela E⋅Satpathy, Minati⋅Cao, Liyun⋅Lai, Yi-Chun⋅Nakshatri, Harikrishna and Donner, David B
Journal of biological chemistry., vol. 282, (no. 1), pp. 445-453, 2007. | Journal Article
2006
Autocrine activation of PDGFR alpha promotes the progression of ovarian cancer
Matei, Daniela E⋅Emerson, RE⋅Lai, Y-C⋅Baldridge, LA⋅Rao, Jianyu Y⋅Yiannoutsos, Constantin T and Donner, David B
Oncogene, vol. 25, (no. 14), pp. 2060-2069, 2006. | Journal Article
 
Autocrine activation of PDGFRalpha promotes the progression of ovarian cancer.
Matei, Daniela E⋅Emerson, R E⋅Lai, Y-C⋅Baldridge, L A⋅Rao, J⋅Yiannoutsos, Constantin T and Donner, D D
Oncogene, vol. 25, (no. 14), pp. 2060-9, 2006/Mar/30. | Journal Article
2005
Hypermethylation of 18S and 28S Ribosomal DNAs Predicts Progression-Free Survival in Patients with Ovarian Cancer
Chan, Michael W⋅Wei, Susan H⋅Wen, Ping⋅Wang, Zailong⋅Matei, Daniela E⋅Liu, Joseph C⋅Liyanarachchi, Sandya⋅Brown, Robert⋅Nephew, Ken⋅Yan, Pearlly S and Huang, Tim H
Clinical Cancer Research, vol. 11, (no. 20), pp. 7376-7383, 2005. | Journal Article
2004
Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation.
Matei, Daniela E⋅Chang, David D and Jeng, Meei-Huey
Clinical Cancer Research, vol. 10, (no. 2), pp. 681-90, 2004/Jan/15. | Journal Article
2002
Gene expression in epithelial ovarian carcinoma
Matei, Daniela E⋅Matei, Daniela⋅Graeber, Thomas⋅Graeber, Thomas G⋅Baldwin, Rae L⋅Baldwin, Rae L⋅Karlan, Beth Y⋅Karlan, Beth Y⋅Rao, Jianyu⋅Rao, Jianyu Y⋅Chang, David D and Chang, David D
Oncogene, vol. 21, (no. 41), pp. 6289-98, Sep 12, 2002. | Journal Article
 
Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility.
Gillan, Lindsay⋅Matei, Daniela E⋅Fishman, David A⋅Gerbin, C S⋅Karlan, Beth Y and Chang, David D
Cancer research, vol. 62, (no. 18), pp. 5358-64, 2002/Sep/15. | Journal Article
1999
Actual 5-year survival of patients with stage IIIB breast carcinoma: phase II trial of methotrexate, vinblastine, adriamycin, cisplatin, and folinic acid.
Madajewicz, Stefan⋅Matei, Daniela E⋅Hentschel, P⋅Kudelka, A⋅Abel, W⋅Fiore, J J⋅DaCosta, N A and Pendyala, L
Cancer Investigation, vol. 17, (no. 7), pp. 463-7, 1999. | Journal Article